Infectious Diseases Physicians, Inc. Report issue

Academic/Hospital Phase 4
Founded: Annandale VA

Organization Overview

First Clinical Trial
2018
NCT03426761
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Infectious Diseases Physicians, Inc.

Active Ingredients

Drugs in Phase 4 Trials (2)

dalbavancin (dalvance) (1 trial)

vancomycin (Vancocin) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis, Infectious (Phase 4)

Communicable Diseases (Phase 4)

Infections (Phase 4)

Osteomyelitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 2